跳到正文
原文
STAT 主站· Jason Mast·· 14 天前精选AI 评分65

AAV基因疗法新病例显示潜在肿瘤风险

STAT+: New tumor cases show common gene therapy tool can come with risk

AI 导读

研究人员和家庭面临AAV基因疗法的肿瘤风险与救命潜力之间的权衡,这将改变某些患者的治疗决策。

推荐理由

揭示了AAV基因疗法与肿瘤风险之间的关联,对患者选择治疗方案有重要影响。

正文 · 原文

By Jason Mast

Nov. 6, 2026

General Assignment Reporter

For two decades, researchers debated whether adeno-associated viruses, the small viruses used to deliver new genes into thousands of patients, could in certain cases drive tumors. That debate is over.

A series of cases this year has presented powerful evidence that adeno-associated viruses, or AAVs, can cause cancer, forcing researchers and families to weigh the newly confirmed risk against the technology’s lifesaving potential — and hopefully determine how to design better therapies in the future.

“It will change the calculus for some patients,” said Sam Mackenzie, a neurologist at University of Rochester, speaking specifically about spinal muscular atrophy patients. 

STAT+ Exclusive Story

Already have an account? Log in

STAT+

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

来源:STAT 主站 · statnews.com